Enzo Biochem (ENZ) Posts Narrower than Expected Q3 Loss
Tweet
Share
E-mailGet Alerts ENZ Hot Sheet
Price: $0.31 --0%
Financial Fact:
Cost of clinical laboratory services: 10.9M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Cost of clinical laboratory services: 10.9M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Enzo Biochem, Inc. (NYSE: ENZ) reported Q3 loss of ($0.05), $0.06 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $25.8 million versus the consensus estimate of $24.77 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- SuperCom (SPCB) Tops Q3 EPS by 43c
- Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
